CHARACTERISTICS
ACTIVE HALF-LIFE 1-1.5 DAYS
CLASSIFICATION ANABOLIC STEROID
DOSAGE MEN 300-700 MG/WEEK
ACNE YES
WATER RETENTION LOW
HBR NO
HEPATOTOXICITY NO
AROMATIZATION YES
ACTIVE SUBSTANCE TESTOSTERONE PROPIONATE
FORM 10 X 1 ML X 100 MG/ML
MANUFACTURER ALPHA PHARMA
CHARACTERISTICS
ACTIVE HALF-LIFE 7-8 DAYS
CLASSIFICATION ANABOLIC STEROID
DOSAGE MEN 300-1500 MG/WEEK
ACNE YES
WATER RETENTION YES
HBR PERHAPS
HEPATOTOXICITY NO
AROMATIZATION YES
ACTIVE SUBSTANCE TESTOSTERONE CYPIONATE
FORM 10 ML X 250 MG/ML
MANUFACTURER HILMA BIOCARE
CHARACTERISTICS
ACTIVE HALF-LIFE 5-7 DAYS
CLASSIFICATION ANABOLIC STEROID
DOSAGE MEN 300-1500 MG/WEEK
ACNE YES
WATER RETENTION YES
HBR PERHAPS
HEPATOTOXICITY NO
AROMATIZATION YES
ACTIVE SUBSTANCE TESTOSTERONE ENANTHATE
FORM 10 ML X 250 MG/ML
MANUFACTURER HILMA BIOCARE
CHARACTERISTICS
ACTIVE HALF-LIFE 1-1.5 DAYS
CLASSIFICATION ANABOLIC STEROID
DOSAGE MEN 300-700 MG/WEEK
ACNE YES
WATER RETENTION LOW
HBR NO
HEPATOTOXICITY NO
AROMATIZATION YES
ACTIVE SUBSTANCE TESTOSTERONE PROPIONATE
FORM 10 ML X 100 MG/ML
MANUFACTURER HILMA BIOCARE
DISEASE INDICATIONS: Asthma
MANUFACTURER: Amgen / AstraZeneca AB
USAGE: Subcutaneous
MEDICINE APPROVED BY:
Food and Drug Administration (FDA)
Tezspire (tezepelumab-ekko) is a prescription medication that belongs to the drug class of monoclonal antibodies. It is used to treat severe asthma in adults and children 12 years of age and older whose condition cannot be managed by their existing asthma medication. Tezspire is the first and only biologic approved for severe asthma without phenotypic or biomarker limitations.
